You Asked: Can Using a Laptop Make You Infertile?
Using a laptop the way its name suggests—on your lap—has long sparked concerns about male fertility due to crotch overheating. Even now, while many laptops run cooler than their predecessors, men planning to father children still need to be mindful of the risks, some experts say. “Human males have testicles outside our bodies for a reason,” says Dr. Jesse N. Mills, an associate clinical professor of urology and director of The Men’s Clinic at UCLA. “Our testicles like to be at least two degrees cooler than the rest of our body, and anything that affects their temperature can affect fertility.” The research linking fertility struggles to hot tubs, saunas and other sources of “scrotal hyperthermia”—or excessively toasty testicles—goes back decades. There’s a clear and negative link between regular exposure to heat and a man’s sperm count and quality. “The heat factor is a well-known negative impact on fertility, so we wanted to know if scrotal temperature really increased with laptop use,” says Dr. Yefim Sheynkin, an associate professor of urology at SUNY Stony Brook who coauthored a 2005 study on laptops and the heat they generate. “We found that, with laptop use, scrotal temperature did increase quite significantly.” After an hour of use, scrotal temperature jumped about 5 degrees Fahrenheit. The way men sit when using a laptop can make matters worse. In a follow-up study, ...
This study provided a more comprehensive description of the seminal exosomes proteome and could also be a resource for further screening of biomarkers and comparative proteomics studies, including those associated with male infertility and prostate cancer.
In conclusion, co-administration of Indian propolis extract may play a promising beneficial role in fertility preservation of males undergoing chemotherapy. Graphical abstract
Polycystic ovary syndrome (PCOS) is the most frequent endocrine disorder in women of reproductive age, affecting 4%-10% of the population. It is a complex disorder classically characterized by chronic oligo- or anovulation, polycystic ovaries, and hyperandrogenism. It is also associated with a number of comorbid conditions, including type 2 diabetes, cardiovascular disease, dyslipidemia, obesity, infertility, and breast and endometrial cancer [1,2]. In addition, psychiatric disorders are observed more often in PCOS patients than in the general population, particularly depressive, anxiety, and eating disorders [3 –6].
Researchers have found that a drug once tested as an anti-cancer treatment may actually help to prevent female infertility caused by cancer radiotherapy.
(Cornell University) An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a new study.
Testicular germ cell tumour Seminoma (SGCT) is the most common type of testicular cancer affecting young adult men. In these men, the semen quality begin to decline along with disturbances in the reproductive hormones. There is a lack of literature examining proteomic changes at the spermatogenic level in samples banked prior to cancer treatment. We set out to identify the sperm proteins and their role in altered semen quality in SGCT patients by proteomics and bioinformatics tool.
The objective of this study was to evaluate the exposure of infertility on development of ovarian cancer and variations in ovarian cancer serum biomarker patterns later in in life.
The objective of this study was to identify the sperm proteins associated with poor sperm quality in HD patients prior to cancer treatment using Liquid Chromatography (LC)-tandem Mass Spectrometry (MS) and in silico methodologies.
Survival rates for childhood cancer have dramatically increased due to advances in therapy, however, infertility often results from treatment. Experimental OTC may help prepubertal females and young women preserve their fertility. The purpose of this study was to explore the decision-making influences, perceived level of control over decision-making, and mood-states of patients and parents who were offered OTC prior to gonadotoxic therapy.
As the number of cancer survivors increases, the burden of cancer-related infertility is becoming more recognized. Little is known about the optimal way to provide fertility preservation decision-making support during the stressful period of time between diagnosis and initiation of cancer treatment. In preparation for developing a patient decision aid, this study assessed informational and decision-making needs of women diagnosed with cancer.